you are here: HomeNewsBiocon
biocon
Jump to
1508 Results Found
  • Trade cautiously, markets will take cue from IIP and CPI numbers Sep 10, 2019 02:06 PM IST

    Trade cautiously, markets will take cue from IIP and CPI numbers

    Index of Industrial Production and Consumer Price Index data will be released on September 12.

  • Temasek, True North and CPPIB in investment talks for stake in Biocon arm: Report Aug 21, 2019 08:57 PM IST

    Temasek, True North and CPPIB in investment talks for stake in Biocon arm: Report

    Founded in 2016, Biocon Biologics India (BBIL) is reported to be the fastest-growing division within Biocon, with a 97 percent growth in revenue to Rs 1,516 crore in FY19 compared to FY18.

  • Biocon's partner Mylan launches first biosimilar of trastuzumab in Australia Aug 01, 2019 09:00 PM IST

    Biocon's partner Mylan launches first biosimilar of trastuzumab in Australia

    The company will be selling the drug under brand name Ogivri, which will be used for the treatment of HER2 sub-type breast cancer and metastatic stomach cancer.

  • Buy Biocon; target of Rs 330: ICICI Direct Jul 26, 2019 04:01 PM IST

    Buy Biocon; target of Rs 330: ICICI Direct

    ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 330 in its research report dated July 26, 2019.

  • Biocon Standalone June 2019 Net Sales at Rs 480.80 crore, down 28.47% Y-o-Y Jul 26, 2019 12:01 PM IST

    Biocon Standalone June 2019 Net Sales at Rs 480.80 crore, down 28.47% Y-o-Y

  • Biocon Consolidated June 2019 Net Sales at Rs 1,465.90 crore, up 30.44% Y-o-Y Jul 26, 2019 12:01 PM IST

    Biocon Consolidated June 2019 Net Sales at Rs 1,465.90 crore, up 30.44% Y-o-Y

  • Biocon stock nosedives as rival launches biosimilar of Herceptin in US Jul 19, 2019 03:36 PM IST

    Biocon stock nosedives as rival launches biosimilar of Herceptin in US

    The biosimilar launched by Amgen and Allergan hit the Biocon scrip, which dropped 8.17 percent and was trading at Rs 241.55 on the BSE at 3 pm.

  • Market Headstart: Nifty likely to open flat; 3 stocks which could give 8-10% return Jul 16, 2019 08:48 AM IST

    Market Headstart: Nifty likely to open flat; 3 stocks which could give 8-10% return

    Trends on SGX Nifty indicate a flat to negative opening for the broader index in India, a fall of 7.5 points or 0.06 percent. Nifty futures were trading around 11,539-level on the Singaporean Exchange.

  • USFDA issues 12 observations for 3 Biocon units in Malaysia Jul 08, 2019 01:31 PM IST

    USFDA issues 12 observations for 3 Biocon units in Malaysia

    As per the USFDA, the Form 483 notifies the company's management of objectionable conditions after the conclusion of an inspection.

  • Biocon hits 52-week low despite getting CGMP from EU regulator for Bengaluru unit Jun 14, 2019 04:45 PM IST

    Biocon hits 52-week low despite getting CGMP from EU regulator for Bengaluru unit

    The European agency inspected Bengaluru unit in March 2019.

  • Biocon falls 2% despite strong Q4 earnings Apr 30, 2019 11:18 AM IST

    Biocon falls 2% despite strong Q4 earnings

    At 1114 hrs, Biocon was quoting Rs 606.50, down 2.15 percent on the BSE.

  • Buy Biocon; target of Rs 730: ICICI Direct Apr 26, 2019 04:12 PM IST

    Buy Biocon; target of Rs 730: ICICI Direct

    ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 730 in its research report dated April 26, 201

  • Biocon Consolidated March 2019 Net Sales at Rs 1,528.80 crore, up 30.72% Y-o-Y Apr 26, 2019 10:15 AM IST

    Biocon Consolidated March 2019 Net Sales at Rs 1,528.80 crore, up 30.72% Y-o-Y

  • Biocon Standalone March 2019 Net Sales at Rs 763.90 crore, up 17.87% Y-o-Y Apr 26, 2019 10:13 AM IST

    Biocon Standalone March 2019 Net Sales at Rs 763.90 crore, up 17.87% Y-o-Y

  • Riding on biosimilar sales, Biocon Q4 profit up 64% at Rs 214 crore Apr 25, 2019 09:01 PM IST

    Riding on biosimilar sales, Biocon Q4 profit up 64% at Rs 214 crore

    Total revenue during the quarter grew by 26 percent to Rs 1,557 crore.

  • Biocon Q4 PAT seen up 35.2% YoY to Rs. 176.2 cr: Kotak Apr 17, 2019 03:12 PM IST

    Biocon Q4 PAT seen up 35.2% YoY to Rs. 176.2 cr: Kotak

    Net Sales are expected to increase by 31.6 percent Y-o-Y (down 0.1 percent Q-o-Q) to Rs. 1,538.7 crore, according to Kotak.

  • Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant Mar 06, 2019 08:09 PM IST

    Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant

    'The inspection at the Bengaluru facility took place between February 25-March 5, resulting in a Form 483 with six observations,' it added.

  • Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India Mar 01, 2019 09:03 PM IST

    Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

    Hamacher comes with more than 20 years of leadership experience in both strategic and operational roles across the value chain in global pharma spanning Asia, Europe and the US, Biocon said in a BSE filing.

  • Cash Market | Biocon at inflection point, can post a sharp rally Feb 08, 2019 07:37 AM IST

    Cash Market | Biocon at inflection point, can post a sharp rally

    Biocon is at the confluence of multiple technical indicators and post a smart rally

  • Buy Biocon; target of Rs 760: ICICI Direct Jan 28, 2019 11:19 AM IST

    Buy Biocon; target of Rs 760: ICICI Direct

    ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 760 in its research report dated January 25, 2019.

  • Biocon trades flat despite strong Q3 results Jan 25, 2019 11:07 AM IST

    Biocon trades flat despite strong Q3 results

    Biocon's Q3 net profit more than doubled, rising 136.34 percent YoY to Rs 217.2 crore.

  • Biocon Q3 net profit zooms over twofold to Rs 217.2 cr Jan 24, 2019 06:40 PM IST

    Biocon Q3 net profit zooms over twofold to Rs 217.2 cr

    Revenues from the biologics vertical, that comprises biosimilars, rose 136 percent to Rs 449 crore driven by the biosimilar Pegfilgrastim gaining market share in the US.

  • Biocon Standalone December 2018 Net Sales at Rs 739.70 crore, up 24.93% Y-o-Y Jan 24, 2019 06:25 PM IST

    Biocon Standalone December 2018 Net Sales at Rs 739.70 crore, up 24.93% Y-o-Y

  • Biocon Consolidated December 2018 Net Sales at Rs 1,540.80 crore, up 45.65% Y-o-Y Jan 24, 2019 06:24 PM IST

    Biocon Consolidated December 2018 Net Sales at Rs 1,540.80 crore, up 45.65% Y-o-Y

  • Biocon chief Kiran Mazumdar-Shaw wants Congress to commit to growth of digital economy Jan 21, 2019 08:25 AM IST

    Biocon chief Kiran Mazumdar-Shaw wants Congress to commit to growth of digital economy

    A billionaire entrepreneur and founder of the country's leading biotechnology firm Biocon, Mazumdar gave this suggestion to the Congress during the party's 'manifesto consultation meeting on IT and BT Economy', chaired by P Chidambaram here.

Sections